Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
05/23/1995 | CA1335662C Peptide derivatives for the treatment and prevention of asthma and the like |
05/23/1995 | CA1335655C Vaccines and diagnostic assays for haemophilus influenzae |
05/23/1995 | CA1335653C Monoclonal antibodies against human interleukin-4 and hybridomas producing the same |
05/19/1995 | WO1995002045A3 Gelatinase antagonists used for treating cancer |
05/19/1995 | CA2134149A1 Compounds containing a fused multiple ring lactam |
05/18/1995 | WO1995013393A1 Hybrid cytokines |
05/18/1995 | WO1995013391A1 Method of treatment using, process of preparing, and composition comprising a recombinant hsv-1 |
05/18/1995 | WO1995013387A1 Tie-2, a novel receptor tyrosine kinase |
05/18/1995 | WO1995013385A2 Thrombin mutants |
05/18/1995 | WO1995013383A1 Methods and reagents for lengthening telomeres |
05/18/1995 | WO1995013382A1 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
05/18/1995 | WO1995013381A1 Telomerase activity assays |
05/18/1995 | WO1995013380A2 Method and reagent for treatment of arthritic conditions |
05/18/1995 | WO1995013379A1 Alteration of sequence of a target molecule |
05/18/1995 | WO1995013377A1 Episomal expression vector for human gene therapy |
05/18/1995 | WO1995013376A1 Gene therapy vector for the treatment of low or defective red blood cell production |
05/18/1995 | WO1995013375A1 Tumor suppressor waf1 |
05/18/1995 | WO1995013374A2 Human and mouse very low density lipoprotein receptors and methods for use of such receptors |
05/18/1995 | WO1995013370A1 Haemophilus transferrin receptor genes |
05/18/1995 | WO1995013367A1 Neural axon outgrowth modulators |
05/18/1995 | WO1995013365A1 Generation of high titers of recombinant aav vectors |
05/18/1995 | WO1995013364A1 In situ modification and manipulation of stem cells of the central nervous system |
05/18/1995 | WO1995013363A1 Hematopoietic stem cells from swine cord blood and uses thereof |
05/18/1995 | WO1995013302A1 Cathepsin-l-specific inhibitor polypeptide |
05/18/1995 | WO1995013301A1 Cross-linked factor viii |
05/18/1995 | WO1995013300A1 New factor viii polypeptides |
05/18/1995 | WO1995013297A2 Improved immunogenic compositions against human gastrin 17 |
05/18/1995 | WO1995013296A1 Receptor specific atrial natriuretic peptides |
05/18/1995 | WO1995013295A1 Human monocyte chemoattractant protein-1 (mcp-1) derivatives |
05/18/1995 | WO1995013294A1 Cytokines from natural killer or t cells |
05/18/1995 | WO1995013292A1 Bcl-2-associated proteins |
05/18/1995 | WO1995013291A1 Neuron-glia cell adhesion molecule, ng-cam, in treatment of nerve damage |
05/18/1995 | WO1995013290A1 Method of treating muscular dystrophy |
05/18/1995 | WO1995013289A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases |
05/18/1995 | WO1995013288A1 Surface membrane proteins and their effect on immune response |
05/18/1995 | WO1995013274A1 Antithrombotic amidinophenylalanine and amidinopyridylalanine derivatives |
05/18/1995 | WO1995013099A1 Osseointegration promoting implant composition, implant assembly and method therefor |
05/18/1995 | WO1995013095A2 Therapy |
05/18/1995 | WO1995013094A1 Treatment of bacterially-induced inflammatory diseases |
05/18/1995 | WO1995013093A1 Treatment of a patient prior to transplantation |
05/18/1995 | WO1995013091A1 Methods of repairing connective tissues |
05/18/1995 | WO1995013090A1 Improved interferon polymer conjugates |
05/18/1995 | WO1995013089A1 Compositions and method for stimulating antibody release by b lymphocytes |
05/18/1995 | WO1995013087A1 Therapeutic regulation of abnormal conjunctival goblet cell mucous secretion |
05/18/1995 | WO1995013086A1 Cytokine restraining agents |
05/18/1995 | WO1995013085A1 Methylated lysine-rich lytic peptides and method of making same by reductive alkylation |
05/18/1995 | WO1995013084A1 Cathepsin d is an amyloidogenic protease in alzheimer's disease |
05/18/1995 | WO1995013083A1 Novel peptides for heparin and low molecular weight heparin anticoagulation reversal |
05/18/1995 | WO1995013082A1 Immunotherapy composition and method |
05/18/1995 | WO1995013079A1 Methylene blue for the treatment or prophylaxis of ancephalopathy caused by ifosfamide |
05/18/1995 | WO1995013069A1 Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone |
05/18/1995 | WO1995013028A1 Implant assembly |
05/18/1995 | WO1995012982A1 Compositions and methods for producing and using homogeneous neuronal cell transplants |
05/18/1995 | WO1995012979A1 Compositions and methods for transduction of cells |
05/18/1995 | WO1995011962A3 Method of controlled genetic transformation of an animal mammary gland and a device for introducing genetic material into the mammary duct of an animal mammary gland |
05/18/1995 | DE4431833C1 Prepn. of an anti-haemophilic factor from a cryo-precipitate |
05/18/1995 | DE4339100A1 Endothelin converting enzyme (ECE) with mol.wt. 250000 dalton |
05/18/1995 | DE4338944A1 New imidazolidone, oxazolidone, thiazolidone or pyrrolidone derivs. |
05/18/1995 | DE4326821A1 New cancer vaccine based on autologous, transfected tumour cells |
05/18/1995 | DE3744826C2 New hybrid protein corresp. to HTLV-3 env and gag determinants |
05/18/1995 | CA2183551A1 Gene therapy vector for the treatment of low or defective red blood cell production |
05/18/1995 | CA2176386A1 Methylene blue for the treatment or prophylaxis of ancephalopathy caused by ifosfamide |
05/18/1995 | CA2176378A1 Bcl-2-associated proteins |
05/18/1995 | CA2176375A1 Novel peptides for heparin and low molecular weight heparin anticoagulation reversal |
05/18/1995 | CA2176284A1 Method of treatment using, process of preparing, and composition comprising a recombinant hsv-1 |
05/18/1995 | CA2176237A1 Treatment of bacterially-induced inflammatory diseases |
05/18/1995 | CA2176217A1 Human monocyte chemoattractant protein-1 (mcp-1) derivatives |
05/18/1995 | CA2176216A1 Compositions and methods for producing and using homogeneous neuronal cell transplants |
05/18/1995 | CA2176208A1 Surface membrane proteins and their effect on immune response |
05/18/1995 | CA2176115A1 Compositions and method for stimulating antibody release by b lymphocytes |
05/18/1995 | CA2176114A1 Cytokines from natural killer or t cells |
05/18/1995 | CA2176024A1 Therapy |
05/18/1995 | CA2176023A1 Implant assembly |
05/18/1995 | CA2175824A1 Method and reagent for treatment of arthritic conditions |
05/18/1995 | CA2175564A1 Cathepsin d is an amyloidogenic protease in alzheimer's disease |
05/18/1995 | CA2175218A1 Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone |
05/18/1995 | CA2173731A1 Neuron-glia cell adhesion molecule, ng-cam, in treatment of nerve damage |
05/18/1995 | CA2173470A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases |
05/18/1995 | CA2151059A1 Cathepsin-l-specific inhibitor polypeptide |
05/17/1995 | EP0653488A1 Looped, hairpin ribozyme |
05/17/1995 | EP0653214A1 Topical antibacterial preparation |
05/17/1995 | EP0653212A1 Liquid antithrombin iii preparation and method of stabilizing the same |
05/17/1995 | EP0653211A1 Blood coagulation normalizer containing tcf-ii as active ingredient |
05/17/1995 | EP0652975A1 Assessment of trans-acting factors allelic variation |
05/17/1995 | EP0652968A1 Defective adenoviruses and corresponding complementation lines |
05/17/1995 | EP0652964A1 $i(K. LACTIS) TRANSALDOLASE GENE PROMOTER AND USE THEREOF |
05/17/1995 | EP0652953A1 Morphogenic protein soluble complex and composition thereof |
05/17/1995 | EP0652952A1 Peptides inhibiting ras protein activity, preparation and use thereof |
05/17/1995 | EP0652951A1 Gdf-1 |
05/17/1995 | EP0652950A1 Generation of xenogeneic antibodies |
05/17/1995 | EP0652948A1 Development of a vector to target gene expression to the epidermis of transgenic animals |
05/17/1995 | EP0652903A1 NEW HUMAN RECOMBINANT $g(g) INTERFERON |
05/17/1995 | EP0652901A1 Carboxy terminal il-6 muteins |
05/17/1995 | EP0652900A1 Thrombin inhibitors |
05/17/1995 | EP0652899A1 A fungicidally active compound |
05/17/1995 | EP0652898A1 Methods for detecting pre-clinical iddm |
05/17/1995 | EP0652897A1 Peptide inhibitors of selectin binding |
05/17/1995 | EP0652895A1 Compounds which inhibit hiv replication |
05/17/1995 | EP0652893A1 Kininogenase inhibitors |
05/17/1995 | EP0652891A1 T-cell membrane inducing factors |